抑郁症抵抗训练:随机对照试验的系统审查和元分析
Yuanbo Chang1, Hai Wang1, Xinbi Zhang1
1Capital University of Physical Education and Sports, Beijing, China.
Frontiers in psychology
|December 31, 2025
概括
抵抗训练 (RT) 在患有抑郁症的成年人中显著降低了抑郁症状. 这项对29项RCT的元分析证实RT是改善心理健康结果的有效干预措施.
科学领域:
- 临床心理学 临床心理学
- 运动科学 运动科学
- 心理健康研究 心理健康研究
背景情况:
- 抑郁症是一个广泛和衰弱的全球心理健康问题.
- 抵抗训练 (RT) 显示出作为抑郁症辅助治疗的前景.
- 缺乏RT的有效性和最佳处方指南的全面综合.
研究的目的:
- 评估抵抗训练 (RT) 对被诊断患有抑郁症的成年人抑郁症状的影响.
- 通过参与者特征和RT处方参数来探索结果的潜在修改.
主要方法:
- 对29项随机对照试验 (RCT) 的系统综述和元分析,涉及2036名患有抑郁症的成年人.
- 搜索的主要数据库 (PubMed,Embase,科学网,Cochrane Central,CNKI) 截至2024年8月.
- 使用随机效应模型汇集数据,对效应修饰剂进行探索性子组分析和对强度进行敏感性分析.
主要成果:
- 与对照条件相比,RT显著减少了抑郁症状 (SMD = -0.94,95% CI: -1.16至 -0.72).
- 在初级和并发性抑郁症子组中都有明显的好处.
- 观察到高异质性 (I2 ≈80%),在大多数探索的变量中没有发现一致的效果修改.
结论:
- 耐力训练 (RT) 对被诊断患有抑郁症的成年人来说,可以显著减少抑郁症状.
- 实质性的异质性需要谨慎地解释潜在的效果修饰剂.
- 未来的研究应侧重于标准化报告和长期跟进,以完善实施并确认耐用性.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
01:18Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
01:30Electroconvulsive Therapy
780
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
780
01:25Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
01:27Depressive Disorders: MDD and Dysthymia
564
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
564